SOURCE Imprimis Pharmaceuticals, Inc.
Mylan's EpiPen continues to dominate the market as a one-time rival looks to come back.
These under-$10 stocks look poised to break out and trade higher from current levels.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.